UNSPSC 51453003: Pexantel

This classification denotes an antihelminthic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HOH9HJ2737. European Medicines Agency schedules Pexantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09740MIG. Pexantel generally arises in the molecular formula C12H22N2O.

The term PEXANTEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, no. 11 1970, list 10.) PEXANTEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pexantel under HS 29335995 and SITC 51576. As of Q4 2014, PEXANTEL remains the US FDA Preferred Term for this commodity. Pexantel bears US NLM identifiers UMLS ID C1882353 and NCI Concept Code C66362. SMILES: O=C(N1CCN(CC1)C)C1CCCCC1.

UNSPSC 51453003 Pexantel, a Commodity code, encompasses pharmaceutical products and related medical supplies that state and local health agencies, emergency services, and purchasing alliances procure through competitive bidding and cooperative purchasing agreements. State and local governments buy naloxone systems, generic pharmaceuticals, over-the-counter products, and emergency medical supplies—items aligned with public health initiatives, fire and rescue operations, and shared pharmacy benefit programs across multiple jurisdictions. Issuing bodies include county health departments, municipal fire services, state health and human services commissions, and multistate cooperative purchasing alliances. Recent opportunities show activity from health departments and emergency management agencies focused on acquisition of specific pharmaceutical quantities and therapeutic products, with purchasing alliances coordinating multi-state procurement to leverage volume across participating entities.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023. The City of Tampa released IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5% bid discount designated for certified Small Local Business Enterprises. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted RFP S1070000015802 on January 20, 2026, with a March 26, 2026 proposal deadline, establishing multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers across Minnesota and Oregon, with pricing weighted at 75% and compliance with current Good Manufacturing Practices and Drug Supply Chain Security Act required.